Regeneron (REGN) Tops Q3 EPS by 132c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $803.03 -0.55%
Revenue Growth %: +21.1%
Financial Fact:
Total other income (expense): 3.08M
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: +21.1%
Financial Fact:
Total other income (expense): 3.08M
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.14, $1.32 better than the analyst estimate of $9.82. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.94 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Regeneron Pharma (REGN) PT Raised to $865 at Piper Sandler
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
